Answers are grounded in this paper and cite their sources.
Guideline presents recommendations for the diagnosis and treatment of thoracic aortic disease, supporting standardized cardiovascular practice.
TABLE OF CONTENTS Preamble ……………………………….280 Introduction ………………………281 1.1. Methodology and Evidence Review … . .281 1.2. Organization of the Writing Committee …283 1.3. Document Review and Approval …… .283 1.4. Scope of the Guideline ……………283 1.4.1. Critical Issues …………… . .283 1.5. Glossary of Terms and Abbreviations Used Throughout the Guideline …… . .284 The Thoracic Aorta ………………… .284 Thoracic Aortic Histopathology …………284 3.1. Atherosclerosis …………………284 3.2. Aneurysms and Dissections ……… . .284 3.3. Vasculitis and Inflammatory Diseases …285 Recommendations for Aortic Imaging Techniques to Determine the Presence and Progression of Thoracic Aortic Disease ……285 4.1. Chest X-Ray ……………………287 4.2. Computed Tomographic Imaging ……287 4.3. Magnetic Resonance Imaging ……… .287 4.4. Echocardiography ……………… .287 Recommendations for Genetic Syndromes …288 Recommendations for Familial Thoracic Aortic Aneurysm and Dissections ……… .289 Recommendations for Bicuspid Aortic Valve and Associated Congenital Variants in Adults .290 Recommendations for Takayasu Arteritis and Giant Cell Arteritis ………………… .290 Recommendations for Estimation of Pretest Risk of Thoracic Aortic Dissection ……… .291 Initial Evaluation and Management of Acute Thoracic Aortic Disease ………………292 10.1. Recommendations for Screening Tests . .292 10.2. Recommendations for Diagnostic Imaging Studies ………………………293 10.3. Recommendations for Initial Management ………………… .293 10.4. Recommendations for Definitive Management ………………… .294 Recommendation for Surgical Intervention for Acute Thoracic Aortic Dissection ……… . .294 Recommendation for Intramural Hematoma Without Intimal Defect ……………… .295 Recommendation for History and Physical Examination for Thoracic Aortic Disease … . .295 Recommendation for Medical Treatment of Patients with Thoracic Aortic Diseases ……295 14.1. Recommendations for Blood Pressure Control ………………………295 14.2. Recommendation for Dyslipidemia … .296 14.3. Recommendation for Smoking Cessation …………………… .297 Recommendations for Asymptomatic Patients With Ascending Aortic Aneurysm ………297 Recommendation for Symptomatic Patients with thoracic Aortic Aneurysm …………298 Recommendations for Open Surgery for Ascending Aortic Aneurysm ……………………299 Recommendations for Aortic Arch Aneurysms ……………………… .299 Recommendations for Descending Thoracic Aorta and Thoracoabdominal Aortic Aneurysms ……………………… .300 Recommendations for Counseling and Management of Chronic Aortic Diseases in Pregnancy ……………………… . .301 Recommendations for Aortic Arch and Thoracic Aortic Atheroma and Atheroembolic Disease . .302 Periprocedural and Perioperative Management ………………………302 22.1. Recommendations for Preoperative Evaluation …………………… .302 22.2. Recommendations for Choice of Anesthetic and Monitoring Techniques ……… .302 22.3. Recommendation for Transfusion Management and Anticoagulation in Thoracic Aortic Surgery ………………………303 22.4. Recommendations for Brain Protection During Ascending Aortic and Transverse Aortic Arch Surgery …………… .303 22.5. Recommendations for Spinal Cord Protection During Descending Aortic Open Surgical and Endovascular Repairs … .303 22.6. Recommendations for Renal Protection During Descending Aortic Open Surgical and Endovascular Repairs ……… . .303 Recommendations for Surveillance of Thoracic Aortic Disease or Previously Repaired Patients ………………………… .303 Recommendation for Employment and Lifestyle in Patients with Thoracic Aortic Disease ……… . .304 Tumors of the Thoracic Aorta ………… .304 Recommendations for Quality Assessment and Improvement for Thoracic Aortic Disease … .304 Appendix 1. Author Relationships with Industry and Other Entities ………………… .306 Appendix 2. Reviewer Relationships with Industry and Other Entities ………………308 References ………………………………309 PREAMBLE It is essential that the medical profession play a central role in critically evaluating the evidence related to drugs, devices, and procedures for the detection, management, or prevention of disease. Properly applied, rigorous, expert analysis of the available data documenting absolute and relative benefits and risks of these therapies and procedures can improve outcomes and reduce costs of care by focusing resources on the most effective strategies. One important use of such data is the production of clinical practice guidelines which, in turn, can provide a foundation for a variety of other applications such as performance measures, appropriate use criteria, clinical decision support tools, and quality improvement tools. The American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) have jointly engaged in the production of guidelines in the area of cardiovascular disease since 1980. The ACCF/AHA Task Force on Practice Guidelines is charged with developing, updating, and revising practice guidelines for cardiovascular diseases and procedures, and the Task Force directs and oversees this effort. Writing committees are charged with assessing the evidence as an independent group of authors to develop, update, or revise recommendations for clinical practice. Experts in the subject under consideration have been selected from both organizations to examine subject-specific data and write guidelines in partnership with representatives from other medical practitioner and specialty groups. Writing committees are specifically charged to perform a formal literature review, weigh the strength of evidence for or against particular treatments or procedures, and include estimates of expected health outcomes where data exist. Patient-specific modifiers, comorbidities, and issues of patient preference that may influence the choice of tests or therapies are considered. When available, information from studies on cost is considered, but data on efficacy and clinical outcomes constitute the primary basis for recommendations in these guidelines. The ACCF/AHA Task Force on Practice Guidelines makes every effort to avoid actual, potential, or perceived conflicts of interest that may arise as a result of industry relationships or personal interests among the writing committee. Specifically, all members of the writing committee, as well as peer reviewers of the document, are asked to disclose all current relationships and those 24 months prior to initiation of the writing effort that may be perceived as relevant. All guideline recommendations require a confidential vote by the writing committee and must be approved by a consensus of the members voting. Members who were recused from voting are noted on the title page of this document. Members must recuse themselves from voting on any recommendation where their relationships with industry (RWI) and other entities apply. If a writing committee member develops a new relationship with industry during his/her tenure, he/she is required to notify guideline staff in writing. These statements are reviewed by the Task Force on Practice Guidelines and all members during each conference call and/or meeting of the writing committee, updated as changes occur, and ultimately published as an appendix to the document. For detailed information regarding guideline policies and procedures, please refer to the methodology manual for ACCF/AHA Guideline Writing Committees.1 RWI and other entities pertinent to this guideline for authors and peer reviewers are disclosed in Appendixes 1 and 2, respectively. Disclosure information for the ACCF/AHA Task Force on Practice Guidelines is also available online at http://www.acc.org/about/overview/ClinicalDocumentsTaskForces.cfm. These practice guidelines are intended to assist healthcare providers in clinical decision making by describing a range of generally acceptable approaches for diagnosis, management, and prevention of specific diseases or conditions. Clinicians should consider the quality and availability of expertise in the area where care is provided. These guidelines attempt to define practices that meet the needs of most in most The recommendations a consensus a of the available current evidence and are intended to improve patient The Task Force that arise where data are to patient these be each guideline to and medical and is an important of of in with these recommendations are effective are of patient and may and other healthcare providers should every effort to the in medical and If these guidelines are as the basis for or the should be improvement in quality of care and with the The regarding care of a particular patient must be by the healthcare and the patient in of all of the by that are in from these guidelines are The guidelines be reviewed by the ACCF/AHA Task Force on Practice Guidelines and current are or from The guidelines are in the issues of the of the American College of Cardiology and ACCF/AHA Task Force on Practice Guidelines ACCF/AHA Task Force on Practice Guidelines 1. 1.1. Methodology and Evidence Review The writing committee a of the medical and literature the use of were to in the were reviewed and were by committee were on the and of the and and thoracic thoracic and thoracic disease and patient thoracic disease and thoracic and Takayasu and or and were with as the primary evidence for the The ACCF/AHA Task Force on Practice Guidelines methodology were to write the and published in in were as the evidence were for information but were in the of The committee reviewed and evidence current recommendations with the of evidence as the data were from clinical or The committee available evidence as data were from a or Evidence as the primary of the recommendation consensus or of the of these evidence is generally in of Studies are as or For for data are available, recommendations are on expert consensus and clinical and are as is the use of for where are and is on clinical When recommendations at are by clinical appropriate clinical are For issues where data are available, a of current practice among the on the writing committee the basis for recommendations and are The for of recommendations and of evidence is in also the an of the of the and an of the of the of Recommendations and of provide with a of the in of clinical are to of the absolute to the relative are as relative or on the in the with all other for those are The writing committee that the evidence for this guideline is in of clinical prior ACCF/AHA those on disease and the of the evidence for this of studies and from with a interest in specific of thoracic disease. The writing committee to on the practitioner with recommendations for and and where as such in the The writing committee the expertise of the and effective practice guidelines staff of the and The writing committee also the and of the writing committee members who were to issues of specialty and on the medical with a guideline at patient 1.2. Organization of the Writing Committee The guideline by a committee of in cardiovascular and For of the ACCF/AHA practice writing expertise been available these of the and of thoracic as well as the who such the and from specialty but specialty organizations that the for with thoracic diseases writing committee members and support of the and are as with the and These organizations the American Association for Thoracic Surgery American College of American Association of for and of of Thoracic and for The American College of and the American College of were also on the writing committee. expertise the of the were for writing committee or by the on Surgery and and and for Blood Pressure and 1.3. Document Review and Approval reviewed by reviewers by the and reviewers by the as well as 1 or reviewers from each of the the and the It also reviewed by reviewers from the Committee and 1 from the All RWI information and to the writing committee and is published in this Appendix approved for by the of the and the and the and and by the American for 1.4. Scope of the Guideline The thoracic disease a range of and disease and to the for Disease Control and diseases of the and for to in the The of to thoracic diseases is studies that the of thoracic disease is to and and these for as as to The of thoracic or is and and in may for to or with thoracic disease be to and the of and and/or for a variety of thoracic diseases by all healthcare the for this document. guideline provide the practitioner with a of and that appropriate care of these can be and The of this guideline is to improve the health outcomes and quality of for all with thoracic disease. guideline diseases any or all of the thoracic with the of and the thoracic diseases are disease are in the and the is to the of in for the 1.4.1. Critical Issues the writing committee this issues Thoracic diseases are and an and Imaging of the thoracic with or in is the to thoracic diseases and for have in of of of thoracic disease. as the use of these also the with as well as these should be as a is in the document. the writing committee recommendations on a for thoracic as in Imaging for at on or diseases is and by For thoracic of for but are the of required for and disease the and of at for and disease thoracic and thoracic prior to such an are to the and with of with are subject to or of this disease with and making under and specific have been in the of the and of thoracic disease been for Risk and clinical are noted in The and of medical in the writing of this guideline provide for of to the of among all medical is evidence that or to of the to these diseases the for of at in the of disease are studies of and of the The in the have the to as for disease. the may to to disease. Medical and treatments are to for or of thoracic 1.5. Glossary of Terms and Abbreviations Used Throughout the Guideline Aneurysm a of an at a in to the expected of the in all and may be the and in may be that in of the are from of the with of by and by the an that with the is also as a of with an in by to the expected Thoracoabdominal the thoracic and the Aortic of the of the with and the of the Dissection and an and The is and should be for those where a in an 2. The thoracic is the the the and the of the the of the at the and to the the at the of the and is the of the and in of the and to the of the and the and the at the the of the and the and to the and the the of the with for as on a of the thoracic Aortic of 2, in and at the of the and thoracic at the to in and Aorta at the at the is of from the on a with and by an a of of with by an of of the and of the can the of the 3.1. Atherosclerosis consensus from the the and of in in and of of at the of the The of the the in may to changes in of of The and in on their may in the and may be the for of from Aneurysms and Dissections Aortic is by and of and of are of of in the but is a of in the is literature the of in this Aortic with and 2, to a by in the The in from in these with that were for a of to the of the but the were with to for a of been in the of thoracic and of from with of and with at the of of and on the of and been in from with or and in from with These are to have of and of also been in of with of in the is in thoracic studies have this or these are in 3.3. Vasculitis and Inflammatory Diseases Giant and Takayasu important with an is by and production disease both and of all OF of should be at to the of and in a and of For by or the should be to the of For the at the should be of For by the should be to the of For the at the should be of of should be and are of The of and/or should be to the of Techniques to and should be of of Aortic Imaging If clinical information is available, can be to to the and and of Thoracic Aortic in Aortic in or of thoracic disease or of of the most appropriate may on patient related and availability of of the and should be to with to the the use of for and the of and with and the of should be The of is the in and the of to the of For who require to an may be to may require to and for as to can thoracic as well as other disease that can and or is to or of the of and and may to or in the of the a of the of and of of are in 2. 4.1. Chest X-Ray may of or that require Chest as a of the of with to other of but also as a to to a or 4.2. Computed Tomographic Imaging the to the and to and to among of and and the required to the and the have to of the and to of of to and of to The for a in the of generally include a to changes of by a to the and of the of and Imaging of the from the thoracic to the the and information to or and of to the appropriate are essential in the information on and the 4.3. Magnetic Resonance Imaging been to be in the of thoracic with and that are to or may those of and of include the to of and and and the patient to or include of during the patient is to care to use in with in with or and of availability on an 4.4. Echocardiography Echocardiography can the of and that the of the disease For of the of both and is the of that a These arise from a or that as a the It is essential that the to from such Arch with Arch Arch with in this is at the of of to the and and months to the of of the of is for with of the is If the is or or the from should be considered. of Patients with or a to to and or should at and months to is of should have from the to the of Patients with should of the and for evidence of of the or of the thoracic If is and are for should be every to or If or should be of of a patient with with and It is to consider of the in all with or a or and an of or by or to or by and/or of For with is to the and the of If the area in of the or by the in a of is have at a and of with have at a of with with of the and/or and in who attempt to or who may be to perform of the and to the of of are and that are with the of thoracic and with at The recommendations on these specific and other and Associated with Familial Thoracic Aortic Aneurysm and Genetic Syndromes Associated with Thoracic Aortic Aneurysm and of who have the also have but the of this to is with or to in have to are other that have or of thoracic to are of in with is a of is to in this is information to the of or for these to are in the literature of with The of or of these is of with also thoracic disease in a of these Aortic is for of with thoracic and/or to those with of If the with and/or is in a should and the with the should of If or of a patient with thoracic and/or are to have thoracic or of is of of the is in with a of thoracic and/or to are for the of of other to thoracic and/or may be in with a and clinical with in these of If or of a patient with thoracic and/or are to have thoracic or to a may be considered. of of with a of thoracic disease with and/or a of thoracic and should be for the of a and thoracic disease. of All with a should have both the and thoracic for evidence of of and Inflammatory Diseases Associated with Thoracic Aortic Aneurysm and Takayasu with of the and as on and of the and of the of the and thoracic and the with of the and thoracic Aorta the from the of of the thoracic of the and Initial for Takayasu and should be at a to at initiation or to reduce the of The of of with Takayasu and should be to disease by and an or of of with Takayasu and should be the is and of The of Takayasu or should include thoracic and or to the of or disease in these of It is to with Takayasu with an is evidence of of of or of of OF OF should any patient with that may thoracic to a of disease that can be to should include specific medical and as well as a to that are with and of or other disease. Patients with in to to thoracic and such as and of or thoracic disease. or thoracic or of that is or in that is in that a or of of Patients with of and/or those of should be a and for of or other with thoracic of Patients with of and/or should be a of in members as is a to thoracic of Patients with of and/or should be or or a of as these to of with or who have a a should be to or the of of All with should be the of and/or and for as with are to thoracic the of central thoracic and Risk for of Thoracic Aortic recommendations provide to improve of The of is to define as can be and prior to may be to Acute is on and among this group may be as of are in The and of are in is as to should be of with and by is in at or or is but is at or and are of this Intimal and and to by or Patients with to this result in or to the with or to or or and with from the from and Aortic and with from the OF 10.1. Recommendations for Screening Tests should be on all who with that may thoracic the relative of the of of should be as a primary for the patient is at for of The role of in the of thoracic disease should be by the of disease as Chest should be on all as may a that the for of Chest should be on all as may an or that are of thoracic the for of and of the or is to or thoracic in at for the disease by of should in to be for by of 10.2. Recommendations for Diagnostic Imaging Studies of a specific to or should be on patient and of If a clinical for but is a should be of 10.3. Recommendations for Initial Management Acute and Initial of thoracic should be at by and as the of should be and to a of or of with to should be as an for of If been and/or other should be to reduce that of should be in the of the of should be prior to as to avoid that may to or of a thoracic of 10.4. Recommendations for Definitive Management and Acute for thoracic and of on should be for all with thoracic of the as as the is or of Acute thoracic the should be for of the of such as of Acute thoracic the should be of to or of For with thoracic all and the of the should be may be with of the should be with with a or with a If a is the should be of It is to to in the of the of For with a of and with a of thoracic the should perform a a and for in both and evidence of a of and with of OF of and other should be for with as well as for who are or of Studies of Medical Treatment of Thoracic Aortic Recommendations for Blood Pressure Control should be to with thoracic diseases to a of or with or to reduce the of and cardiovascular of should be to all with and to reduce the of of For with thoracic is to reduce with and or to the can of is for with to reduce the of of 14.2. Recommendation for Dyslipidemia Treatment with a to a of is for with a disease such as and disease at for of 14.3. Recommendation for Smoking Cessation Smoking and of to at and are to and/or or is as is a at are and of Ascending of and Ascending with and on specific Recommendations for Asymptomatic Patients With Ascending Aortic Aneurysm and Recommendations for Bicuspid Aortic Valve and Associated Congenital Variants in Adults Asymptomatic with thoracic or who are and for the or is or should be for of Patients with or other or thoracic and should at to on the to avoid or of Patients with a of in an that is in should be for of Patients or and who have an or of should be for of the or of the of is for with other or the of or area in by the in of It is for with or a or to the or by or to or by and/or of Patients with of of a thoracic should be for from is or quality of is of and are in in or in with who have disease. of Patients with and and other with of the and of should of the in with a with of For thoracic also the with and is of of the is for the is or is and of of the is for of the for the is and for that also the thoracic with the of For with
No takes yet. Share an insight, caveat, or question.
Hiratzka et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: